InvestorsHub Logo
Followers 167
Posts 13645
Boards Moderated 1
Alias Born 01/26/2016

Re: longfellow95 post# 75579

Friday, 09/23/2016 10:15:08 AM

Friday, September 23, 2016 10:15:08 AM

Post# of 722825
longfellow95,

I believe you are also correct in stating that NWBO is not sharing all that they know. This is what I meant when I said they are holding their cards close to their vest in one of my earlier posts. Rkmatters is also correct in stating that progression as measured by standard measure allowed patients to move off treatment. I am not sure if they could petition to remain or not. Remember this,though, immunologically speaking only the first 3 treatments were spaced within the parameters of sustained effective treatment and there were 2 methods with 3 different cell counts each. Once you add these factors in to results, the top 20% being reported on makes sense due to better method and better dosing. They just didn't say this. Some would argue that they didn't say this because they couldn't but that would be less warranted speculation than what I suggest since they indicated method and cell count preference earlier. Best wishes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News